Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-10-13

FDA Approved: REMIFENTANIL HYDROCHLORIDE — Original Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved Hikma's original-application ANDA for remifentanil hydrochloride, a generic opioid analgesic used to provide anesthesia during surgical procedures.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • REMIFENTANIL HYDROCHLORIDE (REMIFENTANIL HYDROCHLORIDE)

Snippet

ORIG AP for REMIFENTANIL HYDROCHLORIDE (REMIFENTANIL HYDROCHLORIDE)